Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: submandible and submaxillary lymph node swelling; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 78-year-old female patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 10Nov2022 as dose 4 (booster), single (Lot number: GJ6665), in left arm for covid-19 immunisation. The patient's relevant medical history included: "Macular degeneration" (unspecified if ongoing), notes: Macular degeneration She takes PreserVision but is not prescription. She has dry macular degeneration; "high blood pressure" (unspecified if ongoing). Concomitant medication(s) included: ATENOLOL taken for hypertension; PRAVASTATIN. Vaccination history included: BNT162b2 (DOSE 1, SINGLE; Lot number: EM9810; Route of Administration: Intramuscular), administration date: 12Feb2021, when the patient was 76-year-old, for Covid-19 immunization, reaction(s): "She never had any issues with any before this one"; BNT162b2 (DOSE 2, SINGLE; Lot number: EN6208; Route of Administration: Intramuscular), administration date: 12Mar2021, when the patient was 76-year-old, for Covid-19 immunization, reaction(s): "She never had any issues with any before this one"; BNT162b2 (DOSE 3 (BOOSTER), SINGLE; Lot number: 30155BA; Route of Administration: Intramuscular), administration date: 07Oct2021, when the patient was 77-year-old, for Covid-19 immunization, reaction(s): "She never had any issues with any before this one". The following information was reported: LYMPHADENOPATHY (non-serious) with onset 11Nov2022, outcome "recovering", described as "submandible and submaxillary lymph node swelling".  Additional information: The patient received Pfizer covid 19 booster for the fall shot on 03Nov2022. Caller stated it was her 2nd booster. Caller reported her lymph nodes started swelling at midnight on 04Nov2022. Caller stated the sub mandible and sub maxillary lymph nodes were involved. Caller stated the lymph nodes are still slightly swollen. Caller stated her face is not swollen. Caller asked will the lymph nodes recede. This had to be after midnight because she woke up. She is still slightly swollen but has improved slightly and has not gotten worse. The patient took booster dose because everyone says she needs this. The patient knows Pfizer cannot suggest how many days to wait and her lymph nodes are slightly smaller and have no pain unless poking around. The patient asks Pfizer cannot tell her how many days to wait and understands Pfizer cannot give her any information in that direction. The patient did not receive other vaccines within four weeks prior to COVID vaccine. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Anatomical location for dose 4 was left upper arm. The patient clarifies her swelling started on 11Nov2022. 4th dose Pfizer COVID-19 Vaccine: 10Nov2022 booster on 10th. The patient relevant medical history macular degeneration she takes preservision but is not prescription. The patient has dry macular degeneration.